Clinical Trials
3 trialsNCT02653313 2022-11-21
ParvOryx02
Oryx GmbH & Co. KG
Phase 1/2 Completed
NCT01040000 2017-08-04
QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
Precision Biologics, Inc
Phase 1/2 Completed
NCT01808638 2016-03-11
Atu027-I-02
Silence Therapeutics GmbH
Phase 1/2 Completed